← Glossary

AUC (Area Under the Curve)

See also: bioavailabilityclearancehalf-lifepharmacokinetics

AUC (Area Under the Curve) is a pharmacokinetic parameter representing the total exposure of a substance in the systemic circulation over time. It is calculated by measuring the area under the concentration-time curve from administration until the substance is no longer detectable.

Key Concepts

  • Total Exposure: AUC integrates both the concentration and duration of exposure
  • Dose Proportionality: At steady state, AUC is directly proportional to the administered dose (assuming linear pharmacokinetics)
  • Bioavailability Calculation: AUC ratios are used to determine bioavailability of different formulations or routes

Units of Measurement

AUC is expressed in units of concentration multiplied by time:

  • Common units: ng·h/mL, μg·h/mL, or nM·h
  • Reflects the integral of concentration over the sampling period

Types of AUC

  • AUC(0-t): Area from time zero to the last measurable concentration
  • AUC(0-∞): Area extrapolated to infinity, including the terminal elimination phase
  • AUC(0-24): Area over a specific 24-hour period, often used in clinical settings
  • AUC(ss): Area at steady state over one dosing interval

Calculation Methods

Multiple techniques are used to calculate AUC:

  • Trapezoidal Rule: The most common method, approximating the area under discrete data points
  • Model-Based Approaches: Fitting pharmacokinetic models to estimate AUC analytically
  • Non-Compartmental Analysis: Direct calculation from observed concentration-time data

Research Applications

In pharmacokinetic research, AUC is used for:

  • Bioavailability Assessment: Comparing AUC between routes (AUC_test / AUC_IV × 100%)
  • Formulation Comparison: Evaluating how different formulations affect total exposure
  • Accumulation Assessment: Comparing single-dose vs. steady-state AUC
  • Drug-Drug Interactions: Evaluating how co-administered substances affect exposure
  • Clearance Estimation: AUC relates to clearance (CL = Dose / AUC for IV administration)

Relationship to Other PK Parameters

AUC is interconnected with several key parameters:

  • Clearance: Inversely related—higher clearance results in lower AUC for the same dose
  • Half-life: Influences the shape of the curve and how quickly AUC is achieved
  • Volume of Distribution: Affects initial concentrations and curve shape
  • Bioavailability: Only the bioavailable fraction contributes to AUC

Limitations and Considerations

  • Sampling Requirements: Accurate AUC requires sufficient sampling frequency and duration
  • Terminal Extrapolation: AUC(0-∞) requires estimation of the tail beyond the last measurement, introducing uncertainty
  • Non-Linearity: At high doses, AUC may not scale proportionally due to saturation of absorption or elimination pathways
  • Assay Sensitivity: Lower limit of quantification affects when sampling can be stopped

AUC in Peptide Research

For peptide research specifically:

  • AUC helps characterize peptide stability in vivo
  • Enables comparison of different administration routes (SC vs. IM vs. IV)
  • Assesses the impact of peptide modifications on overall exposure
  • Useful for evaluating depot formulations designed for sustained release

Note: AUC describes total exposure but provides no information about when concentrations occur, their magnitude, or biological effects. It should always be interpreted alongside Tmax, Cmax, and half-life for a complete pharmacokinetic profile.